Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

bioAffinity Technologies (BIAF) Receivables - Other (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Receivables - Other for 4 consecutive years, with $26295.0 as the latest value for Q4 2025.

  • Quarterly Receivables - Other fell 5.66% to $26295.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26295.0 through Dec 2025, down 5.66% year-over-year, with the annual reading at $26295.0 for FY2025, 5.66% down from the prior year.
  • Receivables - Other for Q4 2025 was $26295.0 at bioAffinity Technologies, down from $27143.0 in the prior quarter.
  • The five-year high for Receivables - Other was $119363.0 in Q2 2024, with the low at $4730.0 in Q3 2023.
  • Average Receivables - Other over 4 years is $35243.6, with a median of $27143.0 recorded in 2025.
  • The sharpest move saw Receivables - Other soared 940.02% in 2024, then crashed 83.65% in 2025.
  • Over 4 years, Receivables - Other stood at $10489.0 in 2022, then skyrocketed by 181.75% to $29553.0 in 2023, then dropped by 5.68% to $27874.0 in 2024, then decreased by 5.66% to $26295.0 in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $26295.0, $27143.0, and $19516.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.